Rezultati - Thomas, Alissa
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
CLRM-13 RELEVANCE OF RECURSIVE PARTITIONING ANALYSIS (RPA) CLASSIFICATION IN THE CURRENT CARE OF PATIENTS WITH BRAIN METASTASES (BMETS) od Sarai, Guneet, Amidon, Ryan F, Bovi, Joesph A, Thomas, Alissa A, Novicoff, Wendy, Schuetz, Samantha, Singh, Rohit, Chang, Amy, Sheehan, Jason P, Fadul, Camilo E
Izdano 2022Text -
15
Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients od Zhang, Myron, Gulotta, Bryanna, Thomas, Alissa, Kaley, Thomas, Karimi, Sasan, Gavrilovic, Igor, Woo, Kaitlin M., Zhang, Zhigang, Arevalo-Perez, Julio, Holodny, Andrei I., Rosenblum, Marc, Young, Robert J.
Izdano 2016Text -
16
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect od Ades, Steven, Herrera, Diego Adrianzen, Lahey, Tim, Thomas, Alissa A., Jasra, Sakshi, Barry, Maura, Sprague, Julian, Dittus, Kim, Plante, Timothy B., Kelly, Jamie, Kaufman, Peter A., Khan, Farrah, Hammond, Cory J., Gernander, Kelly, Parsons, Polly, Holmes, Chris
Izdano 2022Text -
17
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology od Chukwueke, Ugonma N, Vera, Elizabeth, Acquaye, Alvina, Hervey-Jumper, Shawn L, Odia, Yazmin, Klesse, Laura J, Dunbar, Erin, Sharma, Akanksha, Fonkem, Ekokobe, Thomas, Alissa A, Werbowetski-Ogilvie, Tamra E, Camelo-Piragua, Sandra, Gatson, Na Tosha N, de la Fuente, Macarena I, Armstrong, Terri S, Porter, Alyx B, Jackson, Sadhana
Izdano 2021Text -
18
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma od Thomas, Alissa A., Fisher, Jan L., Rahme, Gilbert J., Hampton, Thomas H., Baron, Udo, Olek, Sven, Schwachula, Tim, Rhodes, C. Harker, Gui, Jiang, Tafe, Laura J., Tsongalis, Gregory J., Lefferts, Joel A., Wishart, Heather, Kleen, Jonathan, Miller, Michael, Whipple, Chery A., de Abreu, Francine B., Ernstoff, Marc S., Fadul, Camilo E.
Izdano 2015Text -
19
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma od Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.
Izdano 2019Text -
20
COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT od Mrugala, Maciej, Ostrom, Quinn, Pressley, Shelley, Thomas, Alissa, Wefel, Jeffrey S, Coven, Scott, Acquaye, Alvina, Haynes, Chas, Agnihotri, Sameer, Lim, Michael, Peters, Katherine, Butowski, Nicholas, Hervey-Jumper, Shawn, Porter, Alyx, Oliver, Kathy, Dunbar, Erin, Taylor, Jennie, Schiff, David, Nassiri, Farshad, Hegi, Monika, Armstrong, Terri, van den Bent, Martin, Chang, Susan, Zadeh, Gelareh, Chheda, Milan
Izdano 2020Text